Lung directed antibody gene transfer confers protection against SARS-CoV-2 infection.
Journal article
Du Y. et al, (2022), Thorax
Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
Journal article
Antepowicz A. et al, (2021), Scientific Reports, 11
RNA-Seq Analysis of the Human Surfactant Air-Liquid Interface Culture Reveals Alveolar Type II Cell-like Transcriptome
Journal article
Munis AM. et al, (2021), Molecular Therapy - Methods & Clinical Development
Vectored Immunoprophylaxis for COVID-19 (COVIP)
Conference paper
Du Y. et al, (2021), MOLECULAR THERAPY, 29, 80 - 80
A human surfactant B deficiency air-liquid interface cell culture model suitable for gene therapy applications
Journal article
Munis AM. et al, (2021), Molecular Therapy - Methods and Clinical Development, 20, 237 - 246
Genome-wide Integration Site Detection Using Cas9 Enriched Amplification-free Long-range Sequencing
Journal article
HYDE S. et al, (2020), Nucleic Acids Research
Identification of AAV serotypes for lung gene therapy in human embryonic stem cell-derived lung organoids.
Journal article
Meyer-Berg H. et al, (2020), Stem Cell Res Ther, 11
DEVELOPMENT OF PROTOCOLS FOR MOUSE GLP-TOXICOLOGY STUDIES
Conference paper
Sinadinos A. et al, (2020), PEDIATRIC PULMONOLOGY, 55, S196 - S196
LOW LEVELS OF CFTR GENE TRANSFER WITH F/HN PSEUDOTYPED LENTIVIRUS ARE SUFFICIENT TO GENERATE ION TRANSPORT CORRECTION IN AIRWAY CELL CULTURES FROM CYSTIC FIBROSIS PATIENTS
Journal article
Sergijenko A. et al, (2020), PEDIATRIC PULMONOLOGY, 55, S73 - S73
SINGLE-CELL ASSAYS FOR QUANTIFYING MRNA AND PROTEIN DURING CYSTIC FIBROSIS GENE THERAPY TRIALS
Conference paper
Sinadinos A. et al, (2020), PEDIATRIC PULMONOLOGY, 55, S203 - S203
TOWARDS A FIRST-IN-HUMAN TRIAL WITH A PSEUDOTYPED LENTIVIRUS
Conference paper
Alton EW. et al, (2020), PEDIATRIC PULMONOLOGY, 55, S224 - S224
Lung-targeting lentiviral vector for passive immunisation against influenza.
Conference paper
Tan TK. et al, (2020), Thorax
Lung-targeting lentiviral vector for passive immunisation against influenza
Journal article
TAN TK. et al, (2020), Thorax
Gene therapy for respiratory diseases; progress and a changing context.
Journal article
Alton EW. et al, (2020), Hum Gene Ther
Human embryonic stem cell derived lung organoids for screening of AAV gene therapy vectors
Working paper
Meyer-Berg H. et al, (2020)
Lung targeting lentiviral vector for passive immunisation against influenza
Working paper
TAN T. et al, (2020)
Improving the Quantification of rSIV.F/HN Vectors for Cystic Fibrosis Gene Therapy Using Droplet Digital PCR
Conference paper
Gamlen T. et al, (2020), MOLECULAR THERAPY, 28, 223 - 223
Large-Scale, High-Throughput Production of rSIV.F/HN Vectors
Conference paper
Viegas MFA. et al, (2020), MOLECULAR THERAPY, 28, 201 - 201
Lentiviral Vector Pseudotyped with Sendai Virus F and HN Proteins Uses Sialylated Glycan Receptors to Efficiently Target Human Airway Cells
Conference paper
Munday RJ. et al, (2020), MOLECULAR THERAPY, 28, 130 - 130
Lentiviral-Mediated Expression of Monoclonal Antibodies in the Lung to Protect Against Influenza
Conference paper
Du Y. et al, (2020), MOLECULAR THERAPY, 28, 60 - 60